Srinivasan

Srinivasan is an accomplished entrepreneur and investor with a strong focus on biopharmaceutical innovation. He is the founder of Avammune Therapeutics, a pioneering company dedicated to small molecule drug discovery aimed at modulating the innate immune system for the treatment of cancer and autoimmune disorders. With a background in both technology and life sciences, Srinivasan combines his expertise to drive advancements in healthcare and improve patient outcomes.